InvestorsHub Logo

58nout

12/22/14 10:41 AM

#83676 RE: maz100577 #83673

maz, with all due respect, you have been trash talking CTIX for years at this point. The advancement of this company's science and pipeline is undeniable. You should buy more and enjoy the fruits of your investment in CTIX stock.

GO CTIX

MinnieM

12/22/14 11:35 AM

#83692 RE: maz100577 #83673

I'm thinking the FDA was given some concrete results to look at this month or they wouldn't have given Brilacidin for ABSSSI the QIDP designation.
http://cellceutix.com/cellceutix-antibiotic-brilacidin-receives-qidp-designation-from-fda/#sthash.Y1xKjDbV.dpbs

Plus, the FDA also gave the go ahead on a phase II for Prurisol this month:
http://cellceutix.com/cellceutix-prurisol-for-psoriasis-fda-agrees-that-phase-2-study-may-begin/#sthash.uRrUhooP.dpbs

So, I don't believe we lack concrete results.

Edit to add: Follow this link and as time progresses you will see more concrete results:
https://clinicaltrials.gov/ct2/results?term=cellceutix





In Reply to 'maz100577'
The problem is CTIX is not "beyond" releases like the one from this a.m. CTIX IS releases like the one from this a.m. That's who they are, that's what they do. There has never been a PR, ever, with statistical results from a human clinical trial. The sp escalation may make it appear like the company is "beyond" releases like this but releases like this are what drove the share price escalation....sp appreciation doesn't change or legitimize the business operation. The lack of concrete results will be the eventual undoing...it's simply a matter of time...